Disagree. EV value is priced now at around 18m. With the IP they have, plus their investments, the MC is looking cheap compared to other companies in the same space as below;
RAP - MC of 132M
PCK - MC of 190M
RHT - MC 40M
I know that the addressable market of CDX compared to those above is different, and some of the above have obtained or close to obtaining FDA approval, still CDX mc of 20m is relative cheap.
Ann: CardieX Update on the Acquisition of 50.5% of inHealth, page-131
Add to My Watchlist
What is My Watchlist?
